当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析

普洛药业

(000739)

  

流通市值:198.95亿  总市值:199.02亿
流通股本:11.58亿   总股本:11.58亿

普洛药业(000739)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.49亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益656920.47万元,未分配利润536299.21万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1225019.63万元,负债568099.16万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入2,447,410,940.299,783,600,915.277,763,882,133.275,444,486,087.31
营业总成本2,132,762,351.948,789,064,728.766,996,741,278.284,838,162,638.1
其他经营收益
营业利润297,277,004.961,070,863,560.26842,655,816.16660,249,384.93
利润总额297,813,987.941,066,198,868.98839,139,546.78658,587,798.37
净利润249,276,739.5890,681,701.93700,189,009.91563,071,412.09
每股收益
其他综合收益1,503,555.52300,145.47937,413.11318,525.63
综合收益总额250,780,295.02890,981,847.4701,126,423.02563,389,937.72
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计7,892,172,263.767,878,965,938.37,585,032,315.138,011,650,969.63
非流动资产:
非流动资产合计4,358,023,993.384,439,297,353.694,516,930,484.214,471,960,429.19
资产总计12,250,196,257.1412,318,263,291.9912,101,962,799.3412,483,611,398.82
流动负债:
流动负债合计5,082,734,367.535,365,151,090.125,316,853,533.245,382,021,923.24
非流动负债:
非流动负债合计598,257,197.64606,763,046.04290,916,547.6345,083,373.18
负债合计5,680,991,565.175,971,914,136.165,607,770,080.845,727,105,296.42
所有者权益(或股东权益):
归属于母公司股东权益合计6,561,026,246.516,338,427,056.56,486,351,400.776,748,563,568.94
股东权益合计6,569,204,691.976,346,349,155.836,494,192,718.56,756,506,102.4
负债和股东权益合计12,250,196,257.1412,318,263,291.9912,101,962,799.3412,483,611,398.82
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,875,562,532.848,544,405,781.596,293,882,351.314,128,407,073.22
经营活动现金流出小计1,750,589,890.577,324,204,500.845,519,858,244.643,721,226,512.9
经营活动产生的现金流量净额124,972,642.271,220,201,280.75774,024,106.67407,180,560.32
投资活动产生的现金流量:
投资活动现金流入小计1,057,022,526.721,312,869,961.15986,330,907.92543,989,471.66
投资活动现金流出小计1,171,539,631.21,685,187,950.81,224,656,435.27672,733,223.93
投资活动产生的现金流量净额-114,517,104.48-372,317,989.65-238,325,527.35-128,743,752.27
筹资活动产生的现金流量:
筹资活动现金流入小计240,000,0002,134,900,0001,620,900,0001,062,900,000
筹资活动现金流出小计226,293,710.752,777,986,444.152,190,685,623.071,283,559,126.65
筹资活动产生的现金流量净额13,706,289.25-643,086,444.15-569,785,623.07-220,659,126.65
汇率变动对现金及现金等价物的影响-16,375,254.92-9,951,342.783,355,523.377,432,261.76
现金及现金等价物净增加额7,786,572.12194,845,504.17-30,731,520.3865,209,943.16
期末现金及现金等价物余额2,932,076,636.352,924,290,064.232,698,713,039.682,794,654,503.22
补充资料:
现金及现金等价物的净增加额-194,845,504.17-65,209,943.16
最新报告期:2026-04-19
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国信证券彭思宇,陈曦炳0.890.991.112026-04-19
西部证券李梦园0.951.151.372026-04-01
中信证券陈竹,王凯旋0.911.061.272026-03-30
中信建投刘若飞,王云鹏,袁清慧,贺菊颖0.891.081.322026-03-29
中泰证券祝嘉琦0.891.061.272026-03-27
TOP↑